6505--Hydralazine HCL Tablets Effective 04/08/2026 to 04/07/2027

Award Notice Posted

Solicitation number
36e79725R0060
Agency
Awarded
to Radha Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
36E79726D0013 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center issued an Award Notice on February 4, 2026, announcing the award of contract 36E79726D0013 to Radha Pharmaceuticals Inc. for the supply of Hydralazine HCL Tablets. The contract was awarded on January 28, 2026, with a total value of $7,450,452.60 and a performance period spanning from April 8, 2026, through April 7, 2027. Hydralazine HCL Tablets are classified under Product Service Code 6505 and represent pharmaceutical preparation manufacturing under NAICS Code 325412. This one-year supply contract will support the VA's pharmaceutical distribution needs for cardiovascular treatment medications.

Notice text

n/a Awarded contract 36E79726D0013 to RADHA PHARMACEUTICALS INC for 7450452.60 on 2026-01-28.

Files

File Type Posted
36E79726D0013_1.docx DOCX document

Notice history

Notice Type Posted
This notice Award Award Notice
6505--Hydralazine RFP Latest solicitation Solicitation
6505--Hydralazine RFP Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Ramipril Capsules RFP NAICS 325412 National Acquisition Center No set-aside
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors